Tinnitus Control By Dopamine Agonist Pramipexole in Presbycusis Patients

Discussion in 'Research News' started by rogerg, Mar 30, 2011.

  1. rogerg Member

    Tinnitus control by dopamine agonist pramipexole in presbycusis patients: A randomized, placebo-controlled, double-blind study

    Objectives/Hypothesis:
    Since the concept of tinnitus dopaminergic pathway emerged, studies have been proposed to investigate if dopaminergic agents influence tinnitus. We hypothesized that pramipexole, an agonist on D2/D3 receptors, may antagonize tinnitus in the presbycusis patients (in the frequency range of 250 to 8,000 Hz) in a dose schedule accepted for the treatment of Parkinson's disease in elderly people.

    Study Design:
    We designed a randomized, prospective, placebo-controlled and double-blind trial.

    Methods:
    Forty presbycusis patients aged 50 years or older with subjective tinnitus were randomized to two groups (20 patients in both). Patients in the drug group took pramipexole over a period of 4 weeks according to a treatment schedule as follows: week 1, 0.088 mg t.i.d.; week 2, 0.18 mg t.i.d.; week 3, 0.7 mg t.i.d.; week 4, 0.18 mg t.i.d. over 3 days and 0.088 mg t.i.d. the rest of the week. Patients in the second group received placebo. Determination of subjective grading of tinnitus perception, the tinnitus handicap inventory (THI) questionnaire and electrocochleography (ECOG) examinations served as the end points. Subjective audiometry was used to produce secondary data. A significant improvement in tinnitus annoyance is found in the group treated with pramipexole versus placebo with respect to inhibition of tinnitus and a decrease of tinnitus loudness greater than 30 dB. However, neither ECOG nor subjective pure-tone threshold audiometry revealed any change in hearing threshold in response to either pramipexole or placebo.

    Conclusions:
    Pramipexole is an effective agent against subjective tinnitus associated with presbycusis at a dose schedule used for the treatment of Parkinson's disease. The drug did not change hearing threshold.
  2. rogerg Member

    What you think? This is INTERESTING..
  3. bertson Member

    Parkinson drug... I dont think my doc is willing to prescrive this :D
  4. rogerg Member

    True! And what are the long term effects of dopamine agonist for a healthy person?? But their tinnitus imrpoved a lot.. over 30db!
  5. greg evanski Member

    I likei it im IN!!!!
    • Staff
    • Lifetime Benefactor

    Jim Manager

    Location:
    San Francisco
    Tinnitus Since:
    04/2007
    Pramipexole is also used by bodybuilders and for treating erectile dysfunction. Maybe I could kill two birds with one stone.:cool:
  6. Gene Graves Member

    My doctor has really tried to help me with my tinnitus. I showed him the article in the Tinnitus magazine and the research to back it up and he said I cannot see that it would hurt to try pramipexole 0.125 mg at the dosage used for someone with Parkinson disease. That was about a month ago. I do believe it has helped reduce my tinnitus. I will continue to take it for a month or two to see what kind of results I may get.
    • Staff
    • Lifetime Benefactor

    Jim Manager

    Location:
    San Francisco
    Tinnitus Since:
    04/2007
    Gene, thanks for the report. I'm interested to see how this goes for you in the longer term. Is your doc an ENT? Please keep us updated with your outcome.
  7. Jim Fletcher Member

    What does "hearing threshold" mean? Gene, have you had any side effects from taking the drug?
  8. Balanced
    • Lifetime Benefactor

    calin Honorary Member

    Tinnitus Since:
    Oct 2011
  9. BOB3000 Member

    Tinnitus Since:
    2002
    Any news about this one?

Share This Page